Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 9;10:1483.
doi: 10.3389/fphar.2019.01483. eCollection 2019.

Use of Herbal Medicine by Pregnant Women: What Physicians Need to Know

Affiliations
Free PMC article
Review

Use of Herbal Medicine by Pregnant Women: What Physicians Need to Know

Sílvia M Illamola et al. Front Pharmacol. .
Free PMC article

Abstract

About 80% of the consumers worldwide use herbal medicine (HMs) or other natural products. The percentage may vary significantly (7%-55%) among pregnant women, depending upon social status, ethnicity, and cultural traditions. This manuscript discusses the most common HMs used by pregnant women, and the potential interactions of HMs with conventional drugs in some medical conditions that occur during pregnancy (e.g., hypertension, asthma, epilepsy). It also includes an examination of the characteristics of pregnant HM consumers, the primary conditions for which HMs are taken, and a discussion related to the potential toxicity of HMs taken during pregnancy. Many cultures have used HMs in pregnancy to improve wellbeing of the mother and/or baby, or to help decrease nausea and vomiting, treat infection, ease gastrointestinal problems, prepare for labor, induce labor, or ease labor pains. One of the reasons why pregnant women use HMs is an assumption that HMs are safer than conventional medicine. However, for pregnant women with pre-existing conditions like epilepsy and asthma, supplementation of conventional treatment with HMs may further complicate their care. The use of HMs is frequently not reported to healthcare professionals. Providers are often not questioning HM use, despite little being known about the HM safety and HM-drug interactions during pregnancy. This lack of knowledge on potential toxicity and the ability to interact with conventional treatments may impact both mother and fetus. There is a need for education of women and their healthcare professionals to move away from the idea of HMs not being harmful. Healthcare professionals need to question women on whether they use any HMs or natural products during pregnancy, especially when conventional treatment is less efficient and/or adverse events have occurred as herbal-drug interactions could be the reason for these observations. Additionally, more preclinical and clinical studies are needed to evaluate HM efficacy and toxicity.

Keywords: efficacy; herbal medicine; herbal-drug interaction; pregnancy; safety.

Similar articles

See all similar articles

References

    1. AstraZeneca LP (2006). “PULMICORT TURBUHALER® 200 mcg (budesonide inhalation powder): Leaflet.” Retrieved 16 May 2018, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020441s020lbl.pdf
    1. AstraZeneca Pharmaceuticals LP (2013). “ACCOLATE® (zafirlukast) TABLETS: Patient information leaflet.” Retrieved 16 May 2018, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020547s033lbl.pdf
    1. Adams J., Lui C. W., Sibbritt D., Broom A., Wardle J., Homer C., et al. (2009). Women’s Use of Complementary and Alternative Medicine During Pregnancy: A Critical Review of the Literature. Birth-Iss Perinat C. 36 (3), 237–245. 10.1111/j.1523-536X.2009.00328.x - DOI - PubMed
    1. Adams J. (2011). Growing popularity of complementary and alternative medicine during pregnancy and implications for healthcare providers. Expert Rev. Obstet. Gynecol. 4 (6), 365–366. 10.1586/eog.11.29 - DOI
    1. Adusi-Poku Y., Vanotoo L., Detoh E. K., Oduro J., Nsiah R. B., Natogmah A. Z. (2015). Type of herbal medicines utilized by pregnant women attending ante-natal clinic in Offinso North district: Are orthodox prescribers aware? Ghana Med. J. 49 (4), 227–232. 10.4314/gmj.v49i4.2 - DOI

LinkOut - more resources

Feedback